Page 13 - Pharma

Drug makers go the digital way, arm medical representatives with apps and tablets

Digital platforms are making it simpler for the drug companies to communicate with doctors

PI Industries plans foray into pharma sector

Company has made an investment to the tune of Rs 321.44 crore in FY16 to set up two new state-of-the-art manufacturing facilities

Pharma firms get time to adopt uniform marketing code

The idea behind a uniform code is to ensure fair marketing in the sector. Medical device makers, too, will have to comply

Pharma shares in focus; Divis Lab, Ajanta, Natco, Torrent Pharma hit record highs

Sequent Scientific, Torrent Pharma, Hikal, Ipca Lab and Aurobindo Pharma were up between 5%-20% on the BSE.

Gujarat gears up to woo fresh pharma investments as tax havens lose relevance

Already several mid-sized cos have started scouting land; state govt setting up pharma and medical devices park; bets on existing eco-system

What is ailing the pharma sector?

Low growth visibility and trouble with regulators have resulted in lack of interest from investors

Govt mulling making pharma mkting uniform code compulsory

Savings to consumers on account of revision and price fixing of essential drugs amounted to Rs 4,988 crore in the last two years

Pharma sector receives Rs 4,975-cr FDI in FY16: Govt

FDI policy provides for 100 per cent FDI under automatic route in greenfield pharma

India rejects 955 pharma patent applications in last 3 years

Nirmala Sitharaman said there was a slowdown in exports from SEZs because of reasons like withdrawal of exemptions of minimum alternate tax

Nifty Pharma index hits 2016 highs

Aurobindo Pharma, Cipla, Cadila and Sun Pharma from the Nifty Pharma index were up 1% each on the NSE.

Pharma recovers, tech lags after Brexit

Pharmaceutical and select automobile stocks, impacted by Britain's exit from the European Union (Brexit), have recouped their losses and are trading higher than the levels they were trading a day prior to the result."The exposure of these firms to Europe is eight-10 per cent of the total exports, so the impact is likely to be contained," said G Chokkalingam, founder, Equinomics Research. The rally has also aided the recovery.The information technology pack, however, continues to languish with key stocks trading one-five per cent below the pre-Brexit level."IT will take some time to recover as a lot of contracts are up for renewal and buyers in the euro region might want to postpone their decision till clarity emerges," said Deven Choksey, managing director, KR Choksey Shares.Tata group companies have a large exposure in the UK and EU, and Tata Motors and Tata Steel are also below the pre-Brexit levels.

USFDA boost for pharma shares; Strides, Alembic up over 7% in a week

Dr Reddy's, Lupin, Cipla, Marksans Pharma, Sanofi India, Aurobindo and JB Chemicals gain over 5% each in one week.

Local growth a challenge for pharma companies

Profitability and growth in the US remain soft; sluggish sales in India add to concerns

Govt weighs relaxing FDI norms in brownfield pharma cos

FDI in the sector is a contentious issue as concerns have been raised over some M&As of Indian pharma companies by foreign giants

FY17 could be a better year for pharma majors

With most concerns priced in, investors may start bottom-fishing as valuations look reasonable

Pharmaceutical sector posts 12% growth in February

Price hikes, new launches help sector maintain average of 12.9% since April 2015, but was lower against February 2015 growth of 18.9%

Pharma crusader Dinesh Thakur takes India's drug regulators to court

Files a PIL suit in the Supreme Court accusing them of failing to enforce rules on drug safety

Kiran Mazumdar-Shaw backs move to have separate pharma ministry

She said there is confusion and chaos in the pharma sector due to multi-ministerial control